期刊文献+

热脉动系统对轻、中度睑板腺功能障碍治疗的临床观察 被引量:4

Clinical observations following thermal pulsation system treatment for mild and moderate meibomian gland dysfunction
原文传递
导出
摘要 目的评价热脉动系统Lipi Flow对轻、中度睑板腺功能障碍(MGD)的患者治疗并随访6个月的临床效果。方法回顾性分析2016年3月至2016年11月在北京佑安医院眼科就诊,并进行Lipi Flow治疗的15例(30眼)睑板腺功能障碍患者的临床资料。受试者分别在治疗前,治疗后3个月,治疗后6个月进行SPEED问卷,不完全眨眼比率(PB),脂质层厚度(LLT),泪膜破裂时间(TBUT),基础泪液分泌量(SIt)和睑板腺开口油脂分泌情况(MGYLS)。结果 SPEED问卷评分在治疗后3个月和6个月时分别为10.20±3.57和9.87±3.68,与治疗前的12.13±2.42相比降低。PB比率在治疗后3个月和6个月时分别为60%和62.45%,与治疗前的72.24%相比下降。LLT在治疗前、治疗后3个月和治疗后6个月分别为(71.70±21.23)nm,(72.03±20.52)nm和(74.60±20.07)nm。TBUT在治疗前、治疗后3个月和治疗后6个月分别为(5.37±2.19)s,(6.33±2.34)s和(6.40±2.50)s。SIt在治疗前、治疗后3个月和治疗后6个月分别为(5.30±4.41)mm,(5.93±4.51)mm和(7.43±7.26)mm。M GYLS在治疗前、治疗后3个月和治疗后6个月分别为3.50±2.11,4.23±1.99和3.83±1.97。LLT,TBUT,SIt和M GYLS三个时间点进行两两比较,无统计学差异。结论热脉动系统可以减轻轻、中度睑板腺功能障碍的主观症状,同时改善不完全眨眼的比率,可以巩固治疗效果长达6个月。 Objective To assess the clinical outcomes of using Lipiflow thermal pulsation system, on mild to moderate meibomian gland dysfunction(MGD), during treatment and at the 3 and 6 months follow up visit. Methods A retrospective analysis of clinical data of MGD patients who sought medical help and underwent LipiFlow treatment at Beijing Youan Hospital from March to November 2016, was conducted. The participants answered a SPEED questionnaire for before, and 3 and 6 months after treatment. In addition, other indicators assessed included, partial blinks(PB), lipid layer thickness(LLT), tear break-up time(TBUT), Schirmer I test(SIT), and meibomian glands yielding liquid secretion(MGYLS). Results SPEED scores at 3 and 6 months, after treatment, were(10.20±3.57)and(9.87±3.68)respectively, significantly lower than(12.13±2.42)before treatment. PB rate assessed at the same time points after treatment was 60% and 62.4%, significantly different than 72.24% before treatment. The other scores, in the order before treatment, 3 and 6 months after treatment, were as follows: LLT scores were(71.70±21.23),(72.03±20.52), and(74.60±20.07)nm; TBUT scores were(5.37±2.19),(6.33±2.34), and(6.40±2.50)s; SIT scores were(5.30±4.41),(5.93±4.51), and(7.43±7.26)mm; and MGYLS scores were(3.50±2.11),(4.23±1.99), and(3.83±1.97). No statistically significant differences were found for LLT, TBUT, SIT, and MGYLS scores. Conclusion Subjective symptoms were improved by thermal pulsation system treatment in mild and moderate MGDs, and PB rates were lowered. The efficacy lasted for up to 6 months.
作者 李上 张薇 卢红双 臧云晓 董宏伟 郭纯刚 潘志强 接英 LI Shang;ZHANG Wei;LU Hongshuang;ZANG Yunxiao;DONG Hongwei;GUO Chungang;PAN Zhiqiang;JIE Ying(Department of Ophthalmology, Beijing You'an Hospital, Capital Medical University, Beijing 100069, China;Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China)
出处 《山东大学耳鼻喉眼学报》 CAS 2018年第3期91-95,共5页 Journal of Otolaryngology and Ophthalmology of Shandong University
基金 国家自然科学基金(81170824) 北京市自然科学基金(7182037) 卫生系统高层次卫生技术人才培养计划(2013-3-055)
关键词 睑板腺功能障碍 热脉动系统 LipiFlow Meibomian gland dysfunction Thermal pulsation system LipiFlow
  • 相关文献

参考文献3

二级参考文献46

  • 1Nichols KK, Foulks GN, Bron AJ, et al. The International Workshop on Meibomian GlandDysfunction: Executive Summary[J]. Invest Ophthalmol Vis Sci, 2011, 52(4): 1922- 1929. 被引量:1
  • 2Lekhanont K, Rojanaporn D, Chuck RS, et al. Prevalence of dry eye in Bangkok, Thailand[J]. Cornea, 2006, 25(10): 1162- 1167. 被引量:1
  • 3Lin PY, Cheng CY, Hsu WM, et al. Association between symptoms and signs of dry eye among an elderly chinese population in Taiwan: The Shihpai eye study[J]. Invest Ophthalmol Vis Sci, 2005, 46(5): 1593-1598. 被引量:1
  • 4Labb6 A, Wang YX, Jie Y, et al. Dry eye disease, dry eye symptoms and depression: the Beijing Eye Study[J]. Br J Ophthalmol, 2013, 97(11): 1399-1403. 被引量:1
  • 5Blackie CA, Carlson AN, Korh DR. Treatment fnr meibomian gland dysfunction and dry eye symptoms with a single-dose vectored thermal pulsation: a review[J]. Curt Opin Ophthahuol, 2015, 26(4): 306-313. 被引量:1
  • 6Benitez Del Castillo JM, Kaereher T, Mansour K, et al. Evaluation of the efficacy, safety, and acceptability of an eyelid warming device for the treatment of meibomian gland dysfunction[J]. Clin Ophthalmol, 2014, 8: 2019-2027. 被引量:1
  • 7Finis D, Kcinig C, Hayajneh J, et al. Six-month effects of a thermodynamic treatment for MGD and implications of meibomian gland atrophy[J]. Cornea, 2014, 33(12): 1265- 1270. 被引量:1
  • 8Lemp MA, Baudouin C, Baum J, et al. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye Workshop (2007)[J]. Ocul Surf, 2007, 5(2): 75-92. 被引量:1
  • 9Korb DR, Blackie CA. Case report: a successful LipiFlow treatment of a single case of meibomian gland dysfunction and dropout[J/OL]. Eye Contact Lens, 2013, 39(3): e 1-3. 被引量:1
  • 10Bron AJ. Evans VE, Smith JA, et al. Grading of corneal and conjunctival staining in the context of other dry eye tests[J]. Cornea, 2003, 22(7): 640-650. 被引量:1

共引文献42

同被引文献47

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部